HUP9802766A2 - Eljárás triazolszármazékok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei - Google Patents

Eljárás triazolszármazékok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei

Info

Publication number
HUP9802766A2
HUP9802766A2 HU9802766A HUP9802766A HUP9802766A2 HU P9802766 A2 HUP9802766 A2 HU P9802766A2 HU 9802766 A HU9802766 A HU 9802766A HU P9802766 A HUP9802766 A HU P9802766A HU P9802766 A2 HUP9802766 A2 HU P9802766A2
Authority
HU
Hungary
Prior art keywords
compound
general formula
carbon
preparation
alkyl
Prior art date
Application number
HU9802766A
Other languages
English (en)
Inventor
Michael Butters
Julie Ann Harrison
Alan John Pettman
Original Assignee
Pfizer Research And Development Company, Nv/S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10778850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9802766(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Research And Development Company, Nv/S.A. filed Critical Pfizer Research And Development Company, Nv/S.A.
Publication of HUP9802766A2 publication Critical patent/HUP9802766A2/hu
Publication of HUP9802766A3 publication Critical patent/HUP9802766A3/hu
Publication of HU224339B1 publication Critical patent/HU224339B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A találmány tárgya eljárás (I) általánős képletű vegyület vagysavaddíciós, vagy bázikűs sója előllítására, ahől R jelentése adőtt esetben 1-3-szőr egymástól függetlenül halőgénatőmmalvagy triflűőr-metilcsőpőrttal szűbsztitűált fenilcsőpőrt, R1 jelentése 1-6 szénatőmős alkilcsőpőrt és Het jelentése adőtt esetben 1-3-szőr egymástól függetlenül 1-4 szénatőmősalkil-, 1-4 szénatőmős alkőxicsőpőrttal, halőgénatőmmal, őxő-, benzil-és/vagy benzilőxicsőpőrttal szűbsztitűált pirimidinil-csőpőrt, őly módőn, hőgy egy (II) általánős képletű vegyületet, ahől Rjelentése a fenti, (III) általánős képletű vegyülettel, ahől R1 és Hetjelentése a fenti és X klór-, bróm- vagy jódatőm, reagáltatják, cink,jód és/vagy Lewis-sav és egy aprőtikűs szerves őldószer jelenlétében,majd kívánt esetben az (I) általánős képletű vegyületet savaddíciósvagy bázikűs sóvá alakítják. A bejelentés vőnatkőzik még a fenti eljárásban kiindűlási anyagkéntalkalmazható, új, (III) általánős képletű vegyületre is. ŕ
HU9802766A 1995-08-05 1996-07-26 Eljárás triazolok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei HU224339B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516121.2A GB9516121D0 (en) 1995-08-05 1995-08-05 Organometallic addition to ketones
PCT/EP1996/003376 WO1997006160A1 (en) 1995-08-05 1996-07-26 Preparation of triazoles by organometallic addition to ketones and intermediates therefor

Publications (3)

Publication Number Publication Date
HUP9802766A2 true HUP9802766A2 (hu) 1999-02-01
HUP9802766A3 HUP9802766A3 (en) 2000-03-28
HU224339B1 HU224339B1 (hu) 2005-08-29

Family

ID=10778850

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802766A HU224339B1 (hu) 1995-08-05 1996-07-26 Eljárás triazolok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei

Country Status (32)

Country Link
US (2) US6586594B1 (hu)
EP (1) EP0871625B1 (hu)
JP (3) JP3211965B2 (hu)
KR (1) KR100269048B1 (hu)
CN (1) CN1076019C (hu)
AR (1) AR003472A1 (hu)
AT (1) ATE256679T1 (hu)
AU (1) AU703337B2 (hu)
BR (1) BR9609960A (hu)
CA (1) CA2228655C (hu)
CZ (1) CZ296975B6 (hu)
DE (1) DE69631160T2 (hu)
DK (1) DK0871625T3 (hu)
EG (1) EG21200A (hu)
ES (1) ES2210382T3 (hu)
GB (1) GB9516121D0 (hu)
HK (1) HK1014944A1 (hu)
HU (1) HU224339B1 (hu)
IL (2) IL131521A (hu)
IN (1) IN190817B (hu)
MX (1) MX9801025A (hu)
MY (1) MY123062A (hu)
NO (1) NO314938B1 (hu)
NZ (1) NZ315651A (hu)
PE (1) PE16897A1 (hu)
PL (1) PL187227B1 (hu)
PT (1) PT871625E (hu)
RU (1) RU2156760C2 (hu)
TR (1) TR199800170T1 (hu)
TW (1) TW442480B (hu)
WO (1) WO1997006160A1 (hu)
ZA (1) ZA966587B (hu)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
ES2337782T3 (es) 2002-07-29 2010-04-29 Rigel Pharmaceuticals, Inc. Metodos para tratar o prevenir enfermedades autoinmunitarias con compuestos de 2,4-pirimidindiamina.
BRPI0413018B8 (pt) * 2003-07-30 2021-05-25 Rigel Pharmaceuticals Inc composto, e, uso de um composto
WO2006028833A1 (en) * 2004-09-01 2006-03-16 Rigel Pharmaceuticals, Inc. Synthesis of 2,4-pyrimidinediamine compounds
WO2006068770A1 (en) 2004-11-24 2006-06-29 Rigel Pharmaceuticals, Inc. Spiro-2, 4-pyrimidinediamine compounds and their uses
CA2590687C (en) * 2004-12-14 2013-09-10 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
WO2007027238A2 (en) * 2005-05-03 2007-03-08 Rigel Pharmaceuticals, Inc. Jak kinase inhibitors and their uses
US8143397B2 (en) 2006-02-01 2012-03-27 Medichem S.A. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
CN1919846B (zh) * 2006-09-14 2013-01-02 大道隆达(北京)医药科技发展有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
KR100889937B1 (ko) 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
GB2452049A (en) * 2007-08-21 2009-02-25 Alpharma Aps Process for the preparation of voriconazole
WO2009084029A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
US20110312977A1 (en) * 2009-02-17 2011-12-22 Glenmark Generics Limited Process for the preparation of voriconazole
KR101109215B1 (ko) * 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
MTP4285B (en) 2009-12-30 2011-07-04 Medichem Sa A 1-(1h-1,2,3-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1, 2, 4- triazol-1yl) butan-2-ol derivative with substially undefined crystal shap for preparing said 1-(1h-1, 2, 4-triazol-1-yl0 butan-2-ol derivative
KR100971371B1 (ko) 2010-02-04 2010-07-20 동국제약 주식회사 신규한 중간체를 이용한 보리코나졸의 제조방법
WO2011110198A1 (en) 2010-03-10 2011-09-15 Synthron B.V. A process for making voriconazole
CN102344441B (zh) * 2010-07-25 2015-05-06 浙江华海药业股份有限公司 一种制备伏立康唑中间体的工艺改进方法
CN101914091B (zh) * 2010-07-25 2015-05-27 浙江华海药业股份有限公司 一种制备伏立康唑中间体的方法
EP2678333B1 (en) * 2011-02-21 2015-04-08 Ranbaxy Laboratories Limited An improved process for the preparation of voriconazole and intermediates thereof
KR101731155B1 (ko) 2011-06-15 2017-04-27 신톤 비.브이. 안정화된 보리코나졸 조성물
CN102516233B (zh) * 2011-12-09 2014-04-09 北京联本医药化学技术有限公司 生产伏立康唑的方法
GR1007802B (el) * 2012-01-31 2013-01-18 Φαρματεν Αβεε, Μεθοδος για την παρασκευη παραγωγου της βρωμοπυρινιδινης
ES2615743T3 (es) 2012-10-15 2017-06-08 Pfizer Ireland Pharmaceuticals Procedimiento de preparación de voriconazol y análogos de los mismos
KR101435741B1 (ko) 2013-01-17 2014-08-29 (주) 에프엔지리서치 신규한 보리코나졸 중간체 및 이를 이용한 보리코나졸의 제조 방법
CN105503834B (zh) * 2015-12-23 2021-03-05 浙江华海药业股份有限公司 一种伏立康唑中间体的合成方法
CN106432198B (zh) 2016-09-08 2022-10-21 浙江华海药业股份有限公司 一种制备伏立康唑拆分中间体的方法
CN106632267B (zh) * 2016-11-09 2019-02-22 中国科学院成都生物研究所 一种伏立康唑的合成方法
CN108276310A (zh) * 2017-01-06 2018-07-13 常州齐晖药业有限公司 一种伏立康唑拆分剂(r)-10-樟脑磺酸的回收方法
CN108586433A (zh) * 2017-07-21 2018-09-28 齐鲁工业大学 具有抗菌活性的伏立康唑盐酸盐
CN109705102A (zh) 2019-02-19 2019-05-03 浙江华海立诚药业有限公司 伏立康唑及其中间体的制备方法
CN110305113A (zh) * 2019-07-05 2019-10-08 镇江市第四人民医院(镇江市妇幼保健院) 一种伏立康唑杂质b的合成方法
CN112442017A (zh) * 2019-08-29 2021-03-05 珠海润都制药股份有限公司 一种采用微通道反应器制备伏立康唑消旋体的方法
CN110724130A (zh) * 2019-11-29 2020-01-24 怀化学院 伏立康唑及其中间体的合成方法
CN111440152B (zh) * 2020-05-18 2022-09-27 浙江诚意药业股份有限公司 一种伏立康唑的制备方法
CN112079819B (zh) * 2020-09-24 2022-06-17 南京易亨制药有限公司 一种改进的伏立康唑消旋体制备方法
CN112645935A (zh) * 2020-12-15 2021-04-13 植恩生物技术股份有限公司 伏立康唑关键中间体的制备方法
CN115724829A (zh) * 2022-12-23 2023-03-03 天津力生制药股份有限公司 一种分离真菌药物中间体杂质的液相色谱制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
DE69500091T2 (de) * 1994-02-01 1997-05-15 Ube Industries 4-Phenylamino-Pyrimidin-Derivate, Verfahren zur Herstellung und diese enthaltende Schädlingsbekämpfungsmittel für Landwirtschaft und Gartenbau

Also Published As

Publication number Publication date
CA2228655C (en) 2003-09-09
CA2228655A1 (en) 1997-02-20
IL131521A0 (en) 2001-01-28
KR100269048B1 (ko) 2000-10-16
ATE256679T1 (de) 2004-01-15
CZ296975B6 (cs) 2006-08-16
JPH10510549A (ja) 1998-10-13
KR19990036174A (ko) 1999-05-25
CN1076019C (zh) 2001-12-12
DE69631160T2 (de) 2004-07-08
RU2156760C2 (ru) 2000-09-27
EP0871625B1 (en) 2003-12-17
PT871625E (pt) 2004-04-30
HK1014944A1 (en) 1999-10-08
TW442480B (en) 2001-06-23
NO980441L (no) 1998-03-26
JP2001026583A (ja) 2001-01-30
PL187227B1 (pl) 2004-06-30
PE16897A1 (es) 1997-05-21
AR003472A1 (es) 1998-08-05
TR199800170T1 (xx) 1998-06-22
MX9801025A (es) 1998-04-30
JP3224532B2 (ja) 2001-10-29
WO1997006160A1 (en) 1997-02-20
IL131521A (en) 2001-08-08
ZA966587B (en) 1998-02-02
US20030181720A1 (en) 2003-09-25
GB9516121D0 (en) 1995-10-04
HUP9802766A3 (en) 2000-03-28
CN1195346A (zh) 1998-10-07
DE69631160D1 (de) 2004-01-29
AU6740396A (en) 1997-03-05
BR9609960A (pt) 1999-02-02
PL324922A1 (en) 1998-06-22
HU224339B1 (hu) 2005-08-29
EP0871625A1 (en) 1998-10-21
JP3211965B2 (ja) 2001-09-25
NO980441D0 (no) 1998-02-02
NO314938B1 (no) 2003-06-16
AU703337B2 (en) 1999-03-25
DK0871625T3 (da) 2004-03-29
IN190817B (hu) 2003-08-23
CZ32798A3 (cs) 1999-03-17
EG21200A (en) 2001-01-31
IL122462A (en) 2001-10-31
US6946555B2 (en) 2005-09-20
JP2001354670A (ja) 2001-12-25
NZ315651A (en) 1999-03-29
MY123062A (en) 2006-05-31
ES2210382T3 (es) 2004-07-01
US6586594B1 (en) 2003-07-01
IL122462A0 (en) 1998-06-15

Similar Documents

Publication Publication Date Title
HUP9802766A2 (hu) Eljárás triazolszármazékok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei
ATE92475T1 (de) Verfahren zur herstellung von 4-benzoyl-5hydroxypyrazolen.
KR840005719A (ko) 트리아졸 유도체의 제조방법
HUP9902473A2 (hu) Új eljárások peszticid hatású vegyületek intermedierjeinek előállítására
KR850001184A (ko) 1,5-벤조티아제핀 유도체의 제조방법
ATE71621T1 (de) Substituierte azolylethanolderivate als pflanzenwachstumsregulatoren.
ATE10838T1 (de) 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
DE69430667T2 (de) Verfahren zur herstellung von fluoralkenylthio heterozyclische derivate
FR2430420A1 (fr) Nouvelles morphinane-6-ones a substituant 8b-alkyle utiles comme intermediaires chimiques
KR100411410B1 (ko) 2-(치환된벤조일)-1,3싸이클로헥산디온의제조방법
DK0873327T3 (da) Fremgangsmåde til fremstilling af 2-chlor-5-chlormethyl-thiazol
KR890014553A (ko) 2α-메틸-2β-(1,2,3-트리아졸-1-일)메틸펜암-3α-카르복실산 유도체의 제조방법
HUP0003059A2 (hu) Eljárás 2-alkiltiobenzoesav-származékok előállítására
HUP9802863A2 (hu) Eljárás difenil-éter-vegyületek nitrálására
IL56507A (en) (trihalomethyl)dimethyloxabicyclohexanone derivatives for the preparation of cis dihalovinyldimethylcyclopropanecarboxylic acids
NO169076C (no) Anhydrider av 1-ethyl-6-fluor-7-klor-4-oxo-1,4-dihydro-kinolin-3-carboxylsyre og borsyrer
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법
FI873097A0 (fi) Foerfarande foer framstaellning av 1-metylaminokinolin-karboxylsyraderivat.
DE69412085D1 (de) Neues verfahren zur herstellung von beta-alkoxyacrylsäure
KR880011087A (ko) 제초제
GB1441718A (en) Polyhalogenated propen-2-yl benzenes
CZ308994A3 (en) Process for preparing 2,4,5-tribromopyrrole-3-carbonitril
DE69733716D1 (de) Verfahren zur herstellung von imidazolderivaten
HUP0003321A2 (hu) Eljárás 2-alkiltiobenzonitril-származékok előállítására
KR850004758A (ko) 피라졸로 피리딘 유도체의 제법

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050620

GB9A Succession in title

Owner name: PFIZER IRELAND PHARMACEUTICALS, IE

Free format text: FORMER OWNER(S): PFIZER RESEARCH AND DEVELOPMENT COMPANY, NV/S.A., IE

MM4A Lapse of definitive patent protection due to non-payment of fees